Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P150033/S230

Micra Functional Testing on pNGHT and NGHT

Medtronic, Inc. · Decision date Sep 8, 2026

MEDTECHLEDGER EXPLANATIONP150033/S230

What did the FDA decide?

The FDA recorded decision OK30 for PMA supplement P150033/S230, dated 2026-09-08, submitted by Medtronic, Inc. as a 30-Day Notice. The supplement covers testing of hybrid electronic module subassemblies on a new or modified hybrid subassembly test system, filed under the process change reason for manufacturer, sterilizer, packager or supplier. The product code is PNJ, device category leadless pacemaker, specialty cardiovascular.

This is a supplement to an existing PMA rather than an approval of a new device or of the whole system. The record does not identify which Micra model or component the hybrid electronic module belongs to, what the test system change involves, or what evidence supported the decision. The source lists no documents, so the decision order and any conditions cannot be reviewed here. Whether the change affects marketed device performance is not stated in the available data.

FDA approval order statement

testing the hybrid electronic module subassemblies on a new/modified hybrid subassembly test system
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Cardiovascular
Decision date
Sep 8, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P150033/S230
Regulatory pathway
PMA supplement
Product code
PNJ
Decision code
OK30
Decision date
Sep 8, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Leadless pacemaker.

Product code
PNJ
FDA device class
3

For the original device and its historical approval scope, see PMA P150033. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P150033 · Original PMA

    MEDTRONIC MICRA TRANSCATHETER PACEMAKER SYSTEM

  2. P150033/S230 received

    Application receipt date recorded by FDA.

  3. P150033/S230 · FDA decision

    30-Day Notice

Timeline entries are records held by MedtechLedger for P150033. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P150033

Product / regulatory recordCompanyPathwayDecision dateSource
Medtronic, Inc.PMA approvalApr 6, 2016FDA

Explore the linked device profile

Other records with product code PNJ

Product / regulatory recordCompanyPathwayDecision dateSource
ABBOTT MEDICALPMA supplementOct 21, 2026FDA
ABBOTT MEDICALPMA approvalMar 31, 2022FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Medtronic, Inc.

Headquarters
Not reported
Brand website
medtronic.com
FDA applicant address
8200 Coral Sea St. N.E, Ms Mvs11, Mounds View, MN, 55112

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records